Table 2
Baseline and outcome characteristics of patients receiving laser treatment
| Patient No | Sex/age | Interval of CRVO and laser (weeks) | Laser used | No of laser sessions | Total No of laser sites attempted | Initial BCVA | Final BCVA | Duration of follow up (months) | Complication |
|---|---|---|---|---|---|---|---|---|---|
| CRVO = central retinal vein occlusion; BCVA = best corrected visual acuity. | |||||||||
| 1 | M/79 | 5 | Argon | 2 | 4 | 8/200 | HM | 31 | Neovascular glaucoma |
| 2 | F/80 | 2 | Diode | 1 | 2 | 2/200 | 2/200 | 31 | |
| 3 | F/54 | 3 | Argon | 2 | 4 | 4/200 | 20/200 | 19 | |
| 4 | M/53 | 12 | Diode | 2 | 4 | 8/200 | 5/200 | 23 | |
| 5 | F/80 | 6 | Argon | 2 | 4 | HM | HM | 7 | |
| 6 | F/78 | 10 | Argon | 1 | 2 | HM | 2/200 | 5 | |
